Global Coalition for Adaptive Research (GCAR) - GBM AGILE

"Global Coalition for Adaptive Research@GCAResearch
Home of the GBM AGILE trial, our mission is to speed the discovery and development of treatments for patients with rare and deadly diseases".

"Global Coalition for Adaptive Research@GCAResearch·Jul 23
GBM AGILE opened in the US in 2019. In less than a year we’ve screened over 230 patients and opened 28 trial sites.More sites in the US and expansion to other countries is underway".

https://twitter.com/GCAResearch

The GBM AGILE trial has screened over 230 patients in less than a year regarding the first drug trialed. That is incredible.

Regards.